Investment in City & County Healthcare Group

RNS Number : 0393V
Graphite Enterprise Trust PLC
09 December 2013
 



 

 

The announcement "Investment in City & County Healthcare Group" for Graphite Enterprise released on 6/12/2013 at 14:52 under RNS No 9558U has been re-released to facilitate onward transmission by third party vendors.

The announcement is unchanged and is reproduced in full below.

 

GRAPHITE ENTERPRISE TRUST PLC

 

5 December 2013

 

Graphite Enterprise Trust PLC ("the Company") is pleased to report the first investment by Graphite Capital Partners VIII ("Graphite VIII"), in which the Company is an investor.

 

Graphite VIII, a fund managed by Graphite Capital, has backed the management buy-out of City & County Healthcare Group ("C&C"), the UK's fourth largest home care provider. The Company has invested £14.2 million in C&C through Graphite VIII. This represents 3.2% of the value of the Company's portfolio as at 31 October and C&C is now the Company's third largest underlying investment.

 

About City & County Healthcare Group

 

C&C provides high quality home care assistance, primarily for the elderly. It also provides specialist care services for young people and adults with more complex or long-term conditions such as learning disabilities, mental health needs and brain injuries. Operating from 64 branches across England, Wales and Northern Ireland, C&C's carers provide care to over 15,000 individuals a year, primarily on behalf of local authorities and the NHS, as well as to private clients.

 

Graphite Capital has a successful long-term track record of investing in health and social care businesses. It has invested in a total of seven elderly care businesses through various stages of the economic cycle over the last 20 years. They all generated strong returns on exit, including Optimum Care and Willowbrook Healthcare which were sold earlier this year.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFSLFSUFDSELE
UK 100

Latest directors dealings